T.Man Pharmaceutical PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	562.06	399.31	348.39	348.04	307.17	22.19
Short-Term Investments	353.68	352.3	450	-	-	-
Cash & Short-Term Investments	915.74	751.62	798.39	348.04	307.17	22.19
Cash Growth	115.42%	-5.86%	129.40%	13.30%	1284.31%	-66.83%
Accounts Receivable	761.38	848.11	596.4	577.79	507.27	256.08
Other Receivables	144.41	189.97	20.57	38.75	21.37	23.94
Receivables	905.79	1,038	616.97	616.54	528.64	280.02
Inventory	634.71	612.66	541.45	481.82	357.96	308.9
Other Current Assets	3.45	3.15	3.51	4.99	32.2	4.21
Total Current Assets	2,460	2,406	1,960	1,451	1,226	615.32
Property, Plant & Equipment	1,230	1,204	1,143	1,048	930.41	742.63
Long-Term Investments	-	-	200	-	-	-
Other Intangible Assets	48.75	45.15	33.84	25.69	12.56	1.23
Long-Term Deferred Tax Assets	44.61	45.24	34.25	38.89	40.69	-
Other Long-Term Assets	83.4	83.71	84	63.18	68.24	199.02
Total Assets	3,867	3,784	3,456	2,627	2,278	1,558
Accounts Payable	476.6	507.62	380.62	331.91	333.08	192.3
Short-Term Debt	850	875	1,080	503.43	535	614.57
Current Portion of Long-Term Debt	-	-	-	33.08	22	16.01
Current Portion of Leases	5.94	5.17	5.66	7.08	4.55	3.01
Current Income Taxes Payable	74.2	54.74	27.53	22.63	110.2	11.34
Current Unearned Revenue	103.06	100.68	72.01	100.29	73.8	-
Other Current Liabilities	9.54	10.09	10.27	23.98	20.46	59.06
Total Current Liabilities	1,519	1,553	1,576	1,022	1,099	896.29
Long-Term Debt	-	-	-	-	33.08	8.33
Long-Term Leases	64.34	63.28	64.95	47.89	44.36	28.28
Pension & Post-Retirement Benefits	50.35	49.02	44.09	35.18	32.13	28.21
Other Long-Term Liabilities	1.18	1.1	0.58	2.39	26.93	25.89
Total Liabilities	1,635	1,667	1,686	1,108	1,236	987
Common Stock	300	300	300	246.43	187.3	187.3
Additional Paid-In Capital	1,394	1,394	1,394	305.88	305.88	305.88
Retained Earnings	789.52	674.88	327.82	993.46	575.48	103.91
Comprehensive Income & Other	-251.78	-251.78	-251.78	-26.37	-26.37	-24.95
Total Common Equity	2,232	2,117	1,770	1,519	1,042	572.14
Minority Interest	-	0	-0	0	0	-0.93
Shareholders' Equity	2,232	2,117	1,770	1,519	1,042	571.21
Total Liabilities & Equity	3,867	3,784	3,456	2,627	2,278	1,558
Total Debt	920.28	943.46	1,151	591.48	638.99	670.21
Net Cash (Debt)	-4.54	-191.84	-352.22	-243.44	-331.82	-648.02
Net Cash Per Share	-0.01	-0.48	-1.03	-0.88	-1.33	-8.98
Filing Date Shares Outstanding	400	400	400	328.57	249.73	249.73
Total Common Shares Outstanding	400	400	400	328.57	249.73	249.73
Working Capital	940.36	852.2	384.21	428.98	126.89	-280.97
Book Value Per Share	5.58	5.29	4.42	4.62	4.17	2.29
Tangible Book Value	2,183	2,072	1,736	1,494	1,030	570.91
Tangible Book Value Per Share	5.46	5.18	4.34	4.55	4.12	2.29
Land	-	124.07	124.07	108.09	94.16	64.95
Buildings	-	1,166	1,104	1,014	897.56	713.66
Machinery	-	597.82	610.1	548.56	448.73	415.39
Construction In Progress	-	84.1	81.02	68.6	93.44	82.16